2-METHYL-1,3-CYCLOHEXADIENE
General Information
Mainterm | 2-METHYL-1,3-CYCLOHEXADIENE |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 1489-57-2 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 73885 |
IUPAC Name | 2-methylcyclohexa-1,3-diene |
InChI | InChI=1S/C7H10/c1-7-5-3-2-4-6-7/h3,5-6H,2,4H2,1H3 |
InChI Key | XMWINMVFKPHMJB-UHFFFAOYSA-N |
Canonical SMILES | CC1=CCCC=C1 |
Molecular Formula | C7H10 |
Wikipedia | 2-methyl-1,3-cyclohexadiene |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 94.157 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 0 |
Complexity | 107.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B g A A A A A A A A A A A A A A A A A A A A A A A A A A A g A A A A A A A A A A A A A A A A G A A A A A A A D A C A A A A C A A A A A A C A A i B C A A A A A A A g A A A I C A A A A A g I A A A A A Q A A A A A A g A A I g A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 0.0 |
Monoisotopic Mass | 94.078 |
Exact Mass | 94.078 |
XLogP3 | None |
XLogP3-AA | 2.1 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 7 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9311 |
Human Intestinal Absorption | HIA+ | 0.9926 |
Caco-2 Permeability | Caco2+ | 0.7925 |
P-glycoprotein Substrate | Non-substrate | 0.6672 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8681 |
Non-inhibitor | 0.9637 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7512 |
Distribution | ||
Subcellular localization | Lysosome | 0.6640 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8091 |
CYP450 2D6 Substrate | Non-substrate | 0.8451 |
CYP450 3A4 Substrate | Non-substrate | 0.6524 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7540 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9544 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9319 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9180 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9663 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6443 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8199 |
Non-inhibitor | 0.9336 | |
AMES Toxicity | Non AMES toxic | 0.9253 |
Carcinogens | Non-carcinogens | 0.6927 |
Fish Toxicity | High FHMT | 0.6027 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7236 |
Honey Bee Toxicity | High HBT | 0.8132 |
Biodegradation | Ready biodegradable | 0.7855 |
Acute Oral Toxicity | III | 0.8419 |
Carcinogenicity (Three-class) | Warning | 0.4486 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.4491 | LogS |
Caco-2 Permeability | 1.9134 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.5027 | LD50, mol/kg |
Fish Toxicity | 1.0135 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.1396 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Hydrocarbons |
Class | Unsaturated hydrocarbons |
Subclass | Branched unsaturated hydrocarbons |
Intermediate Tree Nodes | Not available |
Direct Parent | Branched unsaturated hydrocarbons |
Alternative Parents | |
Molecular Framework | Aliphatic homomonocyclic compounds |
Substituents | Branched unsaturated hydrocarbon - Cyclic olefin - Unsaturated aliphatic hydrocarbon - Olefin - Aliphatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as branched unsaturated hydrocarbons. These are hydrocarbons that contains one or more unsaturated carbon atoms, and an aliphatic branch. |
From ClassyFire